The downregulation of the CARNS1 enzyme that catalyzes the synthesis of carnosine can repress the production of carnosine and thereby increase neuronal vulnerability to the toxic effects of Aβ1-42 oligomers in the EC of female AD patients. The gene discussed is CARNS1; the disease is Alzheimer disease.